PMID: 8605457Mar 23, 1996Paper

Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits

BMJ : British Medical Journal
E B RimmM J Stampfer

Abstract

To review the effect of specific types of alcoholic drink on coronary risk. Systematic review of ecological, case-control, and cohort studies in which specific associations were available for consumption of beer, wine, and spirits and risk of coronary heart disease. 12 ecological, three case-control, and 10 separate prospective cohort studies. Alcohol consumption and relative risk of morbidity and mortality from coronary heart disease. Most ecological studies suggested that wine was more effective in reducing risk of mortality from heart disease than beer or spirits. Taken together, the three case-control studies did not suggest that one type of drink was more cardioprotective than the others. Of the 10 prospective cohort studies, four found a significant inverse association between risk of heart disease and moderate wine drinking, four found an association for beer, and four for spirits. Results from observational studies, where alcohol consumption can be linked directly to an individual's risk of coronary heart disease, provide strong evidence that all alcoholic drinks are linked with lower risk. Thus, a substantial portion of the benefit is from alcohol rather than other components of each type of drink.

References

Nov 2, 1979·JAMA : the Journal of the American Medical Association·C H HennekensS L Mayrent
Aug 25, 1977·The New England Journal of Medicine·K YanoA Kagan
Aug 1, 1992·Lancet·M I Gurr
May 21, 1992·The New England Journal of Medicine·J E MansonC H Hennekens
Feb 1, 1992·International Journal of Epidemiology·G FarchiA Menotti
Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Nov 15, 1990·The American Journal of Cardiology·A L KlatskyG D Friedman
Jan 1, 1990·Stroke; a Journal of Cerebral Circulation·D O WiebersJ P Whisnant
Aug 4, 1988·The New England Journal of Medicine·M J StampferC H Hennekens
Jul 1, 1986·Medicine·R D Moore, T A Pearson
Nov 19, 1987·The New England Journal of Medicine·W C WillettC H Hennekens
May 1, 1986·Atherosclerosis·A A Nanji, S W French
Oct 1, 1986·The American Journal of Cardiology·A L KlatskyG D Friedman
Aug 1, 1985·International Journal of Cardiology·A A Nanji
Jan 10, 1981·Lancet·R E LaPorte, J A Cauley
Dec 1, 1981·British Journal of Addiction·W Schmidt, R E Popham
Jan 1, 1980·Preventive Medicine·R E LaPorteL H Kuller
Jan 1, 1981·American Journal of Public Health·L RosenbergP D Stolley
Sep 28, 1994·JAMA : the Journal of the American Medical Association·P M RidkerC H Hennekens
Jan 7, 1995·BMJ : British Medical Journal·A A Barros D'Sa
Jul 16, 1994·Lancet·S MaxwellG Thorpe
Dec 24, 1994·Lancet·M H Criqui, B L Ringel
Feb 15, 1993·The American Journal of Cardiology·A L Klatsky, M A Armstrong
Jun 1, 1993·American Journal of Public Health·M J StampferD C Walsh

❮ Previous
Next ❯

Citations

Jan 1, 1997·BioFactors·A Sevanian, H Hodis
May 1, 1997·Clinical Cardiology·J Constant
Oct 16, 2007·Journal of Physiology and Biochemistry·J RomeoA Marcos
May 24, 2005·Pflügers Archiv : European journal of physiology·Louis-Jean BordeleauPascal Daleau
Jun 17, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Robert LiptonMeng-Jinn Chen
Feb 12, 2002·Lipids·F Visioli, C Galli
Sep 20, 2007·Current Atherosclerosis Reports·Janne Tolstrup, Morten Grønbaek
Jun 9, 2009·Current Atherosclerosis Reports·Frank B Hu
Apr 29, 2010·Current Diabetes Reports·Swapnil N RajpathakFrank B Hu
May 26, 2005·Current Hypertension Reports·Michael HuntgeburthStephan Rosenkranz
Dec 17, 2009·Genes & Nutrition·Raj LakshmanSamir Zakhari
May 20, 2011·Demography·Theodore D Fuller
Feb 5, 2008·American Journal of Ophthalmology·Elaine W-T ChongRobyn H Guymer
Dec 23, 2003·Life Sciences·Pierre H van GoldeAlbert van de Wiel
Mar 1, 2005·Metabolism: Clinical and Experimental·Raffaele NapoliRoberto Torella
Dec 10, 2003·Obstetrics and Gynecology·Francesmary ModugnoGlenn O Allen
Mar 10, 2004·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Morten Grønbaek
Mar 10, 2004·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Laura B Mann, John D Folts
Sep 21, 2001·The American Journal of Cardiology·A L KlatskyS Sidney
Aug 15, 1997·The American Journal of Cardiology·A L KlatskyG D Friedman
Jan 30, 2003·Clinical Biochemistry·David M GoldbergGeorge J Soleas
Mar 1, 1997·Clinical Biochemistry·G J SoleasD M Goldberg
Nov 4, 2000·Atherosclerosis·J RuidavetsJ Cabanis
Sep 26, 2002·Thrombosis Research·Usha R Pendurthi, L Vijaya Mohan Rao
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·L L KoppesH C Kemper
Sep 6, 2003·International Journal of Cardiology·Renan Stoll MoraesSandra Costa Fuchs
Jan 28, 2003·Journal of Hepatology·James E Everhart
Mar 5, 2003·Social Science & Medicine·Ellen NolteMartin McKee
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T J Cleophas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.